Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights into the Regulation of CGRP-Family Receptors
Joseph J. Gingell, Erica R. Hendrikse, Debbie L. Hay
Trends in Pharmacological Sciences (2018) Vol. 40, Iss. 1, pp. 71-83
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 435
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 162
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
Tessa de Vries, Carlos M. Villalón, Antoinette MaassenVanDenBrink
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107528-107528
Closed Access | Times Cited: 159
Multiple Sclerosis: Inflammatory and Neuroglial Aspects
Giulio Papiri, Giordano D’Andreamatteo, Gabriella Cacchiò, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1443-1470
Open Access | Times Cited: 48
Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
Richard Hargreaves, Jes Olesen
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. 6, pp. 951-970
Closed Access | Times Cited: 116
Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
Gene M. Dubowchik, Charles M. Conway, Alison W. Xin
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 13, pp. 6600-6623
Closed Access | Times Cited: 66
Targeting receptor complexes: a new dimension in drug discovery
Mette Ishoey, Louise S. Clemmensen, David S. Bredt, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 12, pp. 884-901
Closed Access | Times Cited: 66
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
Kathleen Mullin, David Kudrow, Robert Croop, et al.
Neurology (2020) Vol. 94, Iss. 20
Open Access | Times Cited: 64
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
Eleonora De Matteis, Martina Guglielmetti, Raffaele Ornello, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 6, pp. 627-641
Closed Access | Times Cited: 60
How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
Cindy Tiseo, Raffaele Ornello, Francesca Pistoia, et al.
The Journal of Headache and Pain (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 51
Distinct Patterns of Internalization of Different Calcitonin Gene-Related Peptide Receptors
Joseph J. Gingell, Tayla A. Rees, Erica R. Hendrikse, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 296-304
Open Access | Times Cited: 49
CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists?
Michael L. Garelja, Christopher S. Walker, Debbie L. Hay
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 454-459
Open Access | Times Cited: 34
CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
Katharina Kamm
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28
Calcitonin gene‐related peptide (CGRP) is a key molecule released in acute migraine attacks—Successful translation of basic science to clinical practice
Lars Edvinsson
Journal of Internal Medicine (2022) Vol. 292, Iss. 4, pp. 575-586
Open Access | Times Cited: 23
The Epigenetics of Migraine
Farzin Zobdeh, Иван Иванович Еременко, Mikail A. Akan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9127-9127
Open Access | Times Cited: 14
The effects of CGRP in vascular tissue - Classical vasodilation, shadowed effects and systemic dilemmas
Iben Sohn, Majid Sheykhzade, Lars Edvinsson, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173205-173205
Closed Access | Times Cited: 39
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
Nina Sonne, M.A. Karsdal, Kim Henriksen
Molecular Metabolism (2020) Vol. 46, pp. 101109-101109
Open Access | Times Cited: 39
Study of the structural features and solvent effects using ab initio molecular dynamics and energy decomposition analysis of atogepant in water and ammonia
T. Pooventhiran, Bhavya Gangadharappa, Ola A. Abu Ali, et al.
Journal of Molecular Liquids (2022) Vol. 352, pp. 118672-118672
Closed Access | Times Cited: 22
Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension
Ying Kang, Lei Ding, Hang‐Bing Dai, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4217-4217
Open Access | Times Cited: 33
Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors
Michael L. Garelja, Maggie Au, Margaret A. Brimble, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 2, pp. 246-262
Open Access | Times Cited: 32
RAMP1 and RAMP3 Differentially Control Amylin’s Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice
Bernd Coester, Sydney Pence, Soraya Arrigoni, et al.
Neuroscience (2019) Vol. 447, pp. 74-93
Open Access | Times Cited: 31
The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
Willem S van Hoogstraten, Antoinette MaassenVanDenBrink
The Journal of Headache and Pain (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Recent Advances in Pharmacotherapy for Episodic Migraine
Calvin Chan, Peter J. Goadsby
CNS Drugs (2019) Vol. 33, Iss. 11, pp. 1053-1071
Closed Access | Times Cited: 28
Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice
Hannah Louise Zakariassen, Linu M. John, Jens Lykkesfeldt, et al.
Neuropharmacology (2020) Vol. 167, pp. 107987-107987
Closed Access | Times Cited: 24
The CGRP receptor component RAMP1 links sensory innervation with YAP activity in the regenerating liver
Melanie Laschinger, Yang Wang, Gabriela Holzmann, et al.
The FASEB Journal (2020) Vol. 34, Iss. 6, pp. 8125-8138
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top